πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9932391

Proteins with repetitive bacterial-IG-like (Big) domains present in Leptospira species

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9932406

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919058

Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919040

Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, metho

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9920296

Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9913892

Materials and methods for respiratory disease control in canines

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9914773

Anti-human folate receptor beta antibodies and methods of use

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9908841

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in tr

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9902734

Nicotinic acetylcholine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896511

Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease co

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896484

Influenza virus recombinant proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896509

Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890369

Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin leth

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889115

Fitness assay and associated methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884100

Lutzomyia longipalpis polypeptides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884104

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879231

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879065

T cell receptors recognizing MHC class II-restricted MAGE-A3

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873893

Methods and compositions for treating genetically linked diseases of the eye

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873702

Heterocyclic compounds as biogenic amine transport modulators

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868774

Anti-CD22 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9867830

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868769

Mutated Salmonella enteriaca

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868943

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vBβ€”SauS-philPLA

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted